CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
BMI OrganBank Announces Head-to-Head Preclinical Data for OrganBank Kidney Platform

From PR Newswire

April 21, 2026

BMI OrganBank Announces Head-to-Head Preclinical Data for OrganBank Kidney Platform

BMI OrganBank Announces Head-to-Head Preclinical Data for OrganBank Kidney Platform
WINSTON-SALEM, N.C., April 22, 2026 /PRNewswire/ -- BMI OrganBank®, a developer of integrated organ preservation and assessment systems, today announced the presentation of preclinical data evaluating its OrganBank Kidney platform in head-to-head comparison with current standard-of-care cold storage methods. The study, presented at the American Transplant Congress, demonstrated that BMI OrganBank's room-temperature machine perfusion technology significantly improved kidney viability assessment and extended preservation times compared to traditional cold storage. The data showed enhanced functional metrics and reduced injury markers in organs preserved using the OrganBank platform. "These results validate our approach to maintaining organs in a physiologically active state," said David A. Gerber, MD, Chief Medical Officer of BMI OrganBank. "The ability to assess organ function in real-time during preservation is a game-changer for transplant decision-making."

View original article on prnewswire.com

Most Recent

47+ large US data center projects were delayed, withdrawn, or blocked in 2026; Bernstein says ~35% of the planned US data center pipeline is credible

A vast bet on the future of the technology is running into the unforgiving economics of the physical world

Oct 17, 2026

AI debt worries mount as CoreWeave's bond yield tops 15%, insuring SoftBank debt gets pricier, and some Oracle debt trades near 80 to 90 cents on the dollar

Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there are broader problems with the data center build-out.

Oct 17, 2026

Exclusive: ‘I’ve seen this movie before’: A Michigan-raised ex-Tesla exec raises $45 million to break China’s grip on batteries

Steven Prast is old enough to remember when a mobile phone came in a bag. It was too heavy to carry around, so most people mounted it in the car.

Oct 17, 2026

Anthropic is consulting law firms on deal negotiation tactics as it develops AI agents to negotiate on humans' behalf and interact with AI counterparts

Tech companies are being forced to confront the rules of negotiation when machines act on humans' behalf

Oct 17, 2026

Similar Posts

National Kidney Foundation's Innovation Fund Invests in BMI OrganBank to Advance Breakthrough Kidney Transplant Technology

National Kidney Foundation's Innovation Fund invests in BMI OrganBank to advance breakthrough kidney transplant technology.

Jul 14, 2025

BMI OrganBank Secures FDA Breakthrough Device Designation for Innovative Kidney Transplant Technology

BMI OrganBank's kidney preservation device receives FDA Breakthrough Device Designation, expediting clinical studies planned for early 2026.

Aug 4, 2025

BMI OrganBank Secures $3.5 Million NIH Grant to Advance Innovative Kidney Preservation Technology Towards Clinical Trials

BMI OrganBank receives $3.5M NIH grant to advance kidney preservation technology towards clinical trials.

Feb 12, 2025

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation's First Organ Banking Technology

BMI OrganBank partners with Atrium Health and LifeShare Carolinas to launch nation's first organ banking technology.

Mar 9, 2025